Premium
Joint Position Statement from the International Society for Prenatal Diagnosis (ISPD), the Society for Maternal Fetal Medicine (SMFM), and the Perinatal Quality Foundation (PQF) on the use of genome‐wide sequencing for fetal diagnosis
Publication year - 2018
Publication title -
prenatal diagnosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 97
eISSN - 1097-0223
pISSN - 0197-3851
DOI - 10.1002/pd.5195
Subject(s) - exome sequencing , medicine , guideline , position statement , genetic testing , exome , prenatal diagnosis , family medicine , pregnancy , genetics , fetus , pathology , biology , gene , mutation
*Correspondence to: International Society for Prenatal Diagnosis. Email: info@ispdhome.org This is an ISPD Position Statement that has not undergone peer review by this journal. Because Prenatal Diagnosis is the official society journal of the ISPD, it is being published as a courtesy to the ISPD. Funding sources: None Conflicts of interest: The authors of the position statement writing group are listed in the acknowledgements, where details of their conflicts of interest can be found. The authors actively perform research and/or practice in the clinical or laboratory aspects of prenatal genetic diagnosis and fetal medicine. Some had or currently have federal (government supported), foundation research grant funding, or industry support in the form of unrestricted grants, or have pending grant applications for their research in this field. None received funding for the creation of this position statement.